Calabrese G, Fantasia D, Di Gianfilippo R, Stuppia L, Di Lorenzo R, Palka G. Fluorescence in situ hybridization analysis of minimal residual disease and the relevance of the der(9) deletion in imatinib-treated patients with chronic myeloid leukemia. Haematologica [Internet]. 2006Jul.1 [cited 2026Nov.12];91(7):994-5. Available from: https://haematologica.org/article/view/4083